Experts from the U.S. Army have successfully developed an anti-cancer drug called E-75 at the Military Medical Center in San Antonio, Texas, which has a good effect on the treatment of many kinds of tumors.
It is understood that the original intention of the researchers to develop this chemical was to reduce the recurrence rate of breast cancer, but in the course of the study, the researchers unexpectedly discovered that this drug also has other effects: those who take this drug Compared with people taking ordinary cancer control drugs, the probability of the former suffering from colon cancer, prostate cancer, and lung cancer has been significantly reduced.
Researchers selected some women who had breast cancer in the trial and divided them into two groups. One group took control drugs and the other group took E-75 drugs. The results of the study showed that the recurrence rate of breast cancer in patients taking E-75 drugs was only 10%, while the relapse rate of taking control drugs was as high as 20%, which means that E-75 has a positive protective effect.
The researchers explained that E-75 can successfully establish a unique immune system in people's body. This system can search for, identify, and confirm the proteins that are present on the surface of various types of cancer cells, and then perform corresponding immunity. But not all tumors are composed of cells that secrete this protein molecule, which is why E-75 is currently unable to treat all cancer types.
The researchers firmly believe that as long as the study continues on the basis of the drug, new drugs and treatments for cancer will surely emerge in the future.
It is understood that the original intention of the researchers to develop this chemical was to reduce the recurrence rate of breast cancer, but in the course of the study, the researchers unexpectedly discovered that this drug also has other effects: those who take this drug Compared with people taking ordinary cancer control drugs, the probability of the former suffering from colon cancer, prostate cancer, and lung cancer has been significantly reduced.
Researchers selected some women who had breast cancer in the trial and divided them into two groups. One group took control drugs and the other group took E-75 drugs. The results of the study showed that the recurrence rate of breast cancer in patients taking E-75 drugs was only 10%, while the relapse rate of taking control drugs was as high as 20%, which means that E-75 has a positive protective effect.
The researchers explained that E-75 can successfully establish a unique immune system in people's body. This system can search for, identify, and confirm the proteins that are present on the surface of various types of cancer cells, and then perform corresponding immunity. But not all tumors are composed of cells that secrete this protein molecule, which is why E-75 is currently unable to treat all cancer types.
The researchers firmly believe that as long as the study continues on the basis of the drug, new drugs and treatments for cancer will surely emerge in the future.
High Resolution Distance Sensor
JRT produced the high resolution optical distance measurement sensor for 16 years with lower cost. Our distance measuring sensor have small size, high accuracy.
The laser range finder components is characterized by an above-average measured value output frequency, up to 8hz. The miniature laser distance module is also suitable for monitoring defined distance and height during transport.
Distance Measuring Sensor,Accurate Laser Measuring Sensor,High Accuracy Distance Sensor ,Optical Distance Sensors
Chengdu JRT Meter Technology Co., Ltd , https://www.jrt-measure.com